These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 22749599)
1. Eliciting broad neutralizing antibody to HIV-1: envelopes of different lentivirus cross immunization by prime-boost vaccination. Luo Z; Ren L; Zheng Y; Qi Z; Liang H; Liu Y; Hong K; Shao Y Vaccine; 2012 Aug; 30(36):5316-23. PubMed ID: 22749599 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicities of Env glycoproteins from circulating HIV-1 isolates in China focusing on the strategy of "DNA prime plus protein boost". Wang Z; Wang SX; Liu SY; Bao ZY; Zhuang DM; Li L; Zhang CH; Zhang L; Li JY; Lu S Chin Med J (Engl); 2009 Oct; 122(19):2339-45. PubMed ID: 20079137 [TBL] [Abstract][Full Text] [Related]
3. Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization. Townsley S; Mohamed Z; Guo W; McKenna J; Cleveland B; LaBranche C; Beaumont D; Shen X; Yates NL; Pinter A; Tomaras GD; Ferrari G; Montefiori DC; Hu SL J Virol; 2016 Oct; 90(19):8644-60. PubMed ID: 27440894 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates. Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491 [TBL] [Abstract][Full Text] [Related]
6. Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants. Burton S; Spicer LM; Charles TP; Gangadhara S; Reddy PBJ; Styles TM; Velu V; Kasturi SP; Legere T; Hunter E; Pulendran B; Amara R; Hraber P; Derdeyn CA J Virol; 2019 Apr; 93(7):. PubMed ID: 30651354 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies. Bower JF; Li Y; Wyatt R; Ross TM Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193 [TBL] [Abstract][Full Text] [Related]
8. Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits. Rangasamy SP; Menon V; Dhopeshwarkar P; Pal R; Vaniambadi KS; Mahalingam S Vaccine; 2016 May; 34(21):2444-2452. PubMed ID: 27032514 [TBL] [Abstract][Full Text] [Related]
9. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting. Richmond JF; Mustafa F; Lu S; Santoro JC; Weng J; O'Connell M; Fenyö EM; Hurwitz JL; Montefiori DC; Robinson HL Virology; 1997 Apr; 230(2):265-74. PubMed ID: 9143282 [TBL] [Abstract][Full Text] [Related]
10. Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells. Radaelli A; Bonduelle O; Beggio P; Mahe B; Pozzi E; Elli V; Paganini M; Zanotto C; De Giuli Morghen C; Combadière B Vaccine; 2007 Mar; 25(11):2128-38. PubMed ID: 17241705 [TBL] [Abstract][Full Text] [Related]
11. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses. Huang X; Zhu Q; Huang X; Yang L; Song Y; Zhu P; Zhou P Vaccine; 2017 Apr; 35(16):2042-2051. PubMed ID: 28318765 [TBL] [Abstract][Full Text] [Related]
12. Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by semliki forest virus. Forsell MN; Li Y; Sundbäck M; Svehla K; Liljeström P; Mascola JR; Wyatt R; Karlsson Hedestam GB J Virol; 2005 Sep; 79(17):10902-14. PubMed ID: 16103142 [TBL] [Abstract][Full Text] [Related]